SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-19-018170
Filing Date
2019-09-16
Accepted
2019-09-16 17:13:01
Documents
1
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5606
  Complete submission text file 0001213900-19-018170.txt   7069
Mailing Address 24 HANAGAR ST HOD HASHARON L3 4527713
Business Address 24 HANAGAR ST HOD HASHARON L3 4527713 972 472 260 0536
Wize Pharma, Inc. (Issuer) CIK: 0001218683 (see all company filings)

IRS No.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5 MAZEH ST. TEL AVIV L3 65213
Business Address
Franck Amouyal (Reporting) CIK: 0001723469 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52545 | Film No.: 191095251